Biologics Development — How Early Development Teams Use Dynamic Light Scattering To De-Risk Downstream Steps

The hard work of discovery or early development scientists to identify the most promising biologics candidates enables straightforward and efficient downstream process development and manufacturing phases. Viable candidates are selected from assessments of self-interaction and aggregation, colloidal stability, and thermal stability. Dynamic Light Scattering (DLS) reveals size heterogeneity in your sample, detects poorly-folded candidates, and tells you if your candidate is likely to self-associate or form aggregates. Learn how biologics scientists use DLS for more reliable insights into their candidates so they de-risk downstream development.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.